Elena Grueva

Elena Grueva

Auto-generated profile, based on publicly available information

Elena Grueva

University Clinic of Cardiology - Skopje

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Cardiologia Croatica
Verified
Journal Article
Closed access
IMIrena Mitevska
Irena Mitevska
IVIrina Kotlar Velkova
Irina Kotlar Velkova
ENElena Grueva Nastevska
Elena Grueva Nastevska
ESEnes Shehu
Enes Shehu
DPDusan Petkovski
Dusan Petkovski
VPVasil Papestiev
Vasil Papestiev

29 April 2023 in Turkish Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
ACAna Chelikikj
Ana Chelikikj
LPLidija Poposka
Lidija Poposka
EGElena Grueva
Elena Grueva
EKElma Kandi̇c
Elma Kandi̇c
OBOliver Bushljeti̇kJ
Oliver Bushljeti̇kJ
ZZZhan Zi̇mBakov
Zhan Zi̇mBakov
Acute limb ischemia is rare in patients with venous thromboembolism who already receive anticoagulation treatment. Inflammation is a risk factor for thrombus formation. Patients with active ulcerative colitis, especially at the time of exacerbation, are more prone to thromboembolism, both venous and arterial. The risk for thrombosis is 18% higher, with a higher risk of bleeding. To date, there is no contraindication to any anticoagulant drug in patients with ulcerative colitis. We represent a case of a 73 year - old woman with ulcerative colitis exacerbation, hospitalized initially for pulmonary thromboembolism, that developed acute arterial thrombosis when switched on a novel oral anticoagulant.

19 April 2023 in South East European Journal of Cardiology
Verified
Journal Article
Open access
PDF file
IMIrena Mitevska
Irena Mitevska
ACAna Celikic
Ana Celikic
EGElena Grueva
Elena Grueva
ELEmilija Lazarova
Emilija Lazarova
MBMARIJAN BOSEVSKI
MARIJAN BOSEVSKI
BACKGROUND: Ischemic stroke, pulmonary embolism (PE), and acute ST-segment elevation myocardial infarction (STEMI) are very rarely all present in younger patients without classical risk factors or a family history of dyslipidemia or cardiovascular disease. They represent a medical emergency and necessitate fast diagnosis, treatment, and search for etiology, not explained purely by atherosclerosis. Thrombophilia testing should be considered in younger patients with several major thrombotic episodes, although there is much disagreement concerning the importance of homocysteine level testing in patients with arterial and venous thrombotic events, including PE. COVID-19 infection may trigger several thrombotic complications caused by unique immunothrombotic processes. CASE PRESENTATION: A 44-year-old patient complaining of chest pain was admitted at our clinic due to acute anterior STEMI. He has a previous medical history of ischemic stroke, COVID-19 infection, and PE in the past 2 months. Newly, diagnosed lung adenocarcinoma was confirmed by biopsy 10 days before STEMI admission, without surgical or previous hemotherapy. The patient was on regular anticoagulant therapy with rivaroxaban 20 mg OAD and antiplatelet therapy with Aspirin due to previous PE and ischemic stroke. Patient denied standard risk factors, family history for cardiovascular disease or any previous minor or major bleedings, history of anemia, liver, or renal dysfunction. Acute stroke was confirmed by brain computed tomography imaging. Thrombophilia panel testing revealed homozygote mutations for MTHFR 677 gene, heterozygote mutation for integrin subunit alpha 2, and fibrinogen B beta chain) genes. The patient was treated with low molecular weight heparin, aspirin, clopidogrel, and heart failure therapy in the acute phase. Clinical consultations were performed with a team of doctors which included a cardiologist, neurologist, and oncologist. Patients have a high bleeding risk, assessed by HAS-BLEED score of 4. CONCLUSION: Our patient is a rare case of serious multi-vascular thrombotic events with underlying thrombophilia, lung cancer, and past COVID-19 infection complicated by pulmonary embolism, ischemic stroke, and STEMI.